Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Marketing
Kyverna taps CCO as CAR-T autoimmune first comes into view
Kyverna Therapeutics is aiming for the first approval of a CAR-T therapy in an autoimmune disease and has hired a new CCO to help.
Ben Adams
May 5, 2026 9:18am
AZ's Ultomiris hits goal in ph. 3 IgAN trial
Apr 21, 2026 10:35am
UCB partners on meal program for MG patients
Apr 21, 2026 6:26am
Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook
Feb 27, 2026 7:45am
Argenx telegraphs CEO switch as chief drug Vyvgart rolls ahead
Jan 5, 2026 2:12pm
Amgen nabs FDA nod for Uplizna in generalized myasthenia gravis
Dec 12, 2025 9:49am
